The mechanism by which taxanes sensitizes prostate cancer cells to TRAIL-induced apoptosis is not clear and a further study are required to explain how these chemotherapeutics affect the apoptotic signaling pathways. This evidence concerns the gene TNFSF10 and prostate carcinoma.